2013
DOI: 10.1111/cei.12199
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal stem cells control alloreactive CD8+CD28− T cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
30
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 66 publications
(86 reference statements)
5
30
0
Order By: Relevance
“…This study supports the hypothesis that CD8 + T cells, found at a high frequency in the inflammatory joints, could play a role in RA pathogenesis [76]. MSCs are able to suppress CD8 + activation in vitro [77]. Moreover, it has been recently described that MSCs are able to induce the generation of CD8 + CD28 − Treg cells and also enhance their ability to suppress CD4 + T cell proliferation and activation [78].…”
Section: Adaptive Immunity In Ra and The Effect Of Mscssupporting
confidence: 85%
“…This study supports the hypothesis that CD8 + T cells, found at a high frequency in the inflammatory joints, could play a role in RA pathogenesis [76]. MSCs are able to suppress CD8 + activation in vitro [77]. Moreover, it has been recently described that MSCs are able to induce the generation of CD8 + CD28 − Treg cells and also enhance their ability to suppress CD4 + T cell proliferation and activation [78].…”
Section: Adaptive Immunity In Ra and The Effect Of Mscssupporting
confidence: 85%
“…In contrast to the several hundred studies demonstrating MSC immunosuppression of CD4 T cells, only a handful of reports have focused on MSC interactions with CD8 T cells. While a few studies have demonstrated that tissue‐resident MSCs can suppress CD8 T proliferation and cytotoxicity , other reports have shown inconsistent MSC regulation of Tc1 and only one report found inhibition of Tc17 by MSCs . Our study is the first to demonstrate that all sources of MSCs tested including iPSC‐MSCs are strongly immunomodulatory toward CD8 T cells, suppressing effector functions including perforin expression as well as specifically Tc1 and Tc17 subpopulations.…”
Section: Discussionmentioning
confidence: 49%
“…In addition, MSCs can modulate T lymphocyte fate, polarizing naïve CD4 towards a regulatory T cell (Treg) phenotype and shifting the cytokine profile from a T helper cell type 1 (Th1)—in which high levels of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) are secreted—to a Th2 milieu [22]. MSCs can suppress the cytotoxic activity of CD8 cytotoxic T cells [23, 24] as well as natural killer cells (NK) [25], and can also interfere with B cell maturation and antibody production [26, 27]. In addition to interacting with adaptive and innate lymphocyte populations, MSCs have also been shown to modulate the differentiation, expansion, and/or function of myeloid cells towards more immunosuppressive and immunomodulatory phenotypes.…”
Section: Clinical Status Of Msc Therapy For Immune-/inflammation-medimentioning
confidence: 99%